Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Struct Funct ; 226(6): 1879-1891, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-34018041

RESUMO

Interneurons play a significant role in the functional organization of the striatum and some of them display marked plastic changes in dopamine-depleted conditions. Here, we applied immunohistochemistry on brain sections from 6-hydroxydopamine (6-OHDA) mouse model of Parkinson's disease and sham animals to characterize the regional distribution and the morphological and neurochemical changes of striatal interneurons expressing the calcium-binding protein calretinin (CR). Two morphological subtypes of calretinin-immunostained (CR +) interneurons referred, respectively, as small- and medium-sized CR + interneurons were detected in 6-OHDA- and sham-lesioned animals. The small cells (9-12 µm) prevail in the anterior and dorsal striatal regions; they stain intensely for CR and display a single slightly varicose and moderately arborized process. The medium-sized CR + interneurons (15-20 µm) are more numerous than the small CR + cells and rather uniformly distributed within the striatum; they stain weakly for CR and display 2-3 long, slightly varicose and poorly branched dendrites. The density of medium CR + interneurons is significantly decreased in the dopamine-depleted striatum (158 ± 15 neurons/mm3), when compared to sham animals (370 ± 41 neurons/mm3), whereas that of the small-sized CR + interneurons is unchanged (174 ± 46 neurons/mm3 in 6-OHDA-lesioned striatum and 164 ± 22 neurons/mm3 in sham-lesioned striatum). The nucleus accumbens is populated only by medium-sized CR + interneurons, which are distributed equally among the core and shell compartments and whose density is unaltered after dopamine denervation. Our results provide the first evidence that the medium-sized striatal interneurons expressing low level of CR are specifically targeted by dopamine denervation, while the small and intensely immunoreactive CR + cells remain unaffected. These findings suggest that high expression of the calcium-binding protein CR might protect striatal interneurons against an increase in intracellular calcium level that is believed to arise from altered glutamate corticostriatal transmission in Parkinson's disease.


Assuntos
Doença de Parkinson , Animais , Calbindina 2/metabolismo , Proteínas de Ligação ao Cálcio , Corpo Estriado/metabolismo , Interneurônios/metabolismo , Camundongos , Oxidopamina/toxicidade
2.
J Neural Transm (Vienna) ; 125(3): 279-290, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-28168621

RESUMO

This paper reviews the major organizational features of calretinin interneurons in the dorsal striatum of rodents and primates, with some insights on the state of these neurons in Parkinson's disease and Huntington's chorea. The rat striatum harbors medium-sized calretinin-immunoreactive (CR+) interneurons, whereas the mouse striatum is pervaded by medium-sized CR+ interneurons together with numerous small and highly immunoreactive CR+ cells. The CR interneuronal network is even more elaborated in monkey and human striatum where, in addition to the small- and medium-sized CR+ interneurons, a set of large CR+ interneurons occurs. The majority of these giant CR+ interneurons, which are unique to the primate striatum, also display immunoreactivity for choline acetyltransferase (ChAT), a faithful marker of cholinergic neurons. The expression of CR and/or ChAT by the large striatal interneurons appears to be seriously compromised in Parkinson's disease and Huntington's chorea. The species differences noted above have to be considered to better understand the role of CR interneurons in striatal organization in both normal and pathological conditions.


Assuntos
Calbindina 2/metabolismo , Corpo Estriado/patologia , Doença de Huntington/metabolismo , Interneurônios/metabolismo , Doença de Parkinson/metabolismo , Animais , Corpo Estriado/metabolismo , Modelos Animais de Doenças , Doença de Huntington/patologia , Interneurônios/patologia , Doença de Parkinson/patologia , Primatas , Roedores
3.
Sci Rep ; 7: 41432, 2017 01 27.
Artigo em Inglês | MEDLINE | ID: mdl-28128287

RESUMO

The loss of nigrostriatal dopamine neurons in Parkinson's disease induces a reduction in the number of dendritic spines on medium spiny neurons (MSNs) of the striatum expressing D1 or D2 dopamine receptor. Consequences on MSNs expressing both receptors (D1/D2 MSNs) are currently unknown. We looked for changes induced by dopamine denervation in the density, regional distribution and morphological features of D1/D2 MSNs, by comparing 6-OHDA-lesioned double BAC transgenic mice (Drd1a-tdTomato/Drd2-EGFP) to sham-lesioned animals. D1/D2 MSNs are uniformly distributed throughout the dorsal striatum (1.9% of MSNs). In contrast, they are heterogeneously distributed and more numerous in the ventral striatum (14.6% in the shell and 7.3% in the core). Compared to D1 and D2 MSNs, D1/D2 MSNs are endowed with a smaller cell body and a less profusely arborized dendritic tree with less dendritic spines. The dendritic spine density of D1/D2 MSNs, but also of D1 and D2 MSNs, is significantly reduced in 6-OHDA-lesioned mice. In contrast to D1 and D2 MSNs, the extent of dendritic arborization of D1/D2 MSNs appears unaltered in 6-OHDA-lesioned mice. Our data indicate that D1/D2 MSNs in the mouse striatum form a distinct neuronal population that is affected differently by dopamine deafferentation that characterizes Parkinson's disease.


Assuntos
Denervação , Dopamina/metabolismo , Neostriado/metabolismo , Neurônios/metabolismo , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Animais , Espinhas Dendríticas/metabolismo , Dinorfinas/metabolismo , Encefalinas/metabolismo , Camundongos Transgênicos , Núcleo Accumbens/metabolismo , Núcleo Accumbens/patologia , Oxidopamina , Substância Negra/metabolismo , Substância Negra/patologia , Tirosina 3-Mono-Oxigenase/metabolismo , Área Tegmentar Ventral/metabolismo , Área Tegmentar Ventral/patologia
4.
AORN J ; 50(6): 1236-40, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2515799

RESUMO

From the time the patients enter the hospital until discharge, the accelerated recovery technique demands more intensive treatment from nurses and physicians. These patients do not require a stay in the intensive care unit, but they do require intensive nursing care. Savings from reduced length of stay, however, far outweigh the nursing care cost. As the emphasis on earlier discharge in health care grows, accelerated recovery in abdominal surgery and other major procedures will become more common. With the accelerated recovery technique, the patient has an active, demanding role in his or her recovery. Much is expected of these patients during pulmonary physiotherapy, which begins shortly after admission and is maintained until discharge. The more conscientiously a patient participates in the physiotherapy, the more quickly and comfortably he or she will leave the hospital. The patient can honestly take credit for a quick recovery.


Assuntos
Abdome/cirurgia , Gastroenteropatias/terapia , Intubação Gastrointestinal , Complicações Pós-Operatórias/terapia , Nutrição Enteral , Gastroenteropatias/enfermagem , Humanos , Cuidados Intraoperatórios , Alta do Paciente , Cuidados Pós-Operatórios , Complicações Pós-Operatórias/enfermagem , Sucção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...